Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes Zoster
This study has been completed.
Study NCT00006131   Information provided by National Center for Research Resources (NCRR)
First Received: August 3, 2000   Last Updated: May 22, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Herpes Zoster
Immunologic Deficiency Syndromes
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
DNA Virus Infections
Herpesviridae Infections
Immune System Diseases
Pathologic Processes
Virus Diseases
Interventions listed in this trial
Valacyclovir
More general drug interventions related to this trial
Anti-Infective Agents
Antiviral Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Center for Research Resources (NCRR)
University of Texas


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services